Regulators of Glucose Uptake in Thyroid Cancer Cell Lines
Reads0
Chats0
TLDR
Understanding the mechanisms of glucose transportation in normal and pathologic thyroid tissues is critically important and could provide significant insights in science of diagnosis and treatment of thyroid disease.Abstract:
Thyroid cancer is the most common sort of endocrine-related cancer with more prevalent in women and elderly individuals which has quickly widespread expansion in worldwide over the recent decades. Common features of malignant thyroid cells are to have accelerated metabolism and increased glucose uptake to optimize their energy supply which provides a fundamental advantage for growth. In tumor cells the retaining of required energy charge for cell survival is imperative, indeed glucose transporters are enable of promoting of this task. According to this relation it has been reported the upregulation of glucose transporters in various types of cancers. Human studies indicated that poor survival can be occurred following the high levels of GLUT1 expression in tumors. GLUT-1 and GLUT3 are the glucose transporters which seems to be mainly engaged with the oncogenesis of thyroid cancer and their expression in malignant tissues is much more than in the normal one. They are promising targets for the advancement of anticancer strategies. The lack of oncosuppressors have dominant effect on the membrane expression of GLUT1 and glucose uptake. Overexpression of hypoxia inducible factors have been additionally connected with distant metastasis in thyroid cancers which mediates transcriptional regulation of glycolytic genes including GLUT1 and GLUT3. Though the physiological role of the thyroid gland is well illustrated, but the metabolic regulations in thyroid cancer remain evasive. In this study we discuss proliferation pathways of the key regulators and signaling molecules such as PI3K-Akt, HIF-1, MicroRNA, PTEN, AMPK, BRAF, c-Myc, TSH, Iodide and p53 which includes in the regulation of GLUTs in thyroid cancer cells. Incidence of deregulations in cellular energetics and metabolism are the most serious signs of cancers. In conclusion, understanding the mechanisms of glucose transportation in normal and pathologic thyroid tissues is critically important and could provide significant insights in science of diagnosis and treatment of thyroid disease.read more
Citations
More filters
Journal ArticleDOI
Glucose Transporters as a Target for Anticancer Therapy.
Monika Pliszka,Leszek Szablewski +1 more
TL;DR: In this paper, the authors present possibilities and how glucose transporters can be used in anticancer therapy, and they also suggest that therapeutic inhibition of GLUT1 and GLUT3 may be a method in treatment of cancer patients.
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase (cancerytyrosine phosphorylationysignal transductionyprotein tyrosine phosphatase)
Michael P. Myers,Javor P. Stolarov,Charis Eng,J Ing Li,S Teven I. Wang,H. Wigler,Ramon Parsons,Nicholas K. Tonks +7 more
TL;DR: In this article, the authors showed that recombinant P-TEN dephosphorylated protein and peptide substrates phosphorylated on serine, threonine, and tyrosine residues.
Journal ArticleDOI
Anti-Warburg Effect of Melatonin: A Proposed Mechanism to Explain its Inhibition of Multiple Diseases.
TL;DR: In this paper, the authors proposed that melatonin's function as a glycolytic explains its actions in inhibiting a variety of diseases, such as the Warburg effect in solid tumors and in other pathological cells.
Journal ArticleDOI
The crosstalk between HIFs and mitochondrial dysfunctions in cancer development.
Xingting Bao,Jinhua Zhang,Guomin Huang,Junfang Yan,Caipeng Xu,Zhihui Dou,Chao Sun,Hong Zhang +7 more
TL;DR: In this paper, the crosstalk between hypoxia-inducible factors (HIFs) and mitochondrial dysfunctions in cancer development has been discussed, and it is shown that the stability and activity of HIFs are closely influenced by mitochondrial dysfunction related to tricarboxylic acid cycle, electron transport chain components, mitochondrial respiration, and mitochondrial related proteins.
Journal ArticleDOI
Targeted Anti-Mitochondrial Therapy: The Future of Oncology
TL;DR: How functional mitochondria help cancer cells’ survival in the harsh tumor microenvironment, immune evasion, progression, and treatment resistance is described and how targeting mitochondria may improve oncological outcomes is explained.
References
More filters
Journal ArticleDOI
Targeting HIF-1 for cancer therapy
TL;DR: Hypoxia-inducible factor 1 (HIF-1) activates the transcription of genes that are involved in crucial aspects of cancer biology, including angiogenesis, cell survival, glucose metabolism and invasion.
Journal ArticleDOI
AKT/PKB signaling: navigating downstream.
TL;DR: Those Akt substrates that are most likely to contribute to the diverse cellular roles of Akt, which include cell survival, growth, proliferation, angiogenesis, metabolism, and migration are discussed.
Journal ArticleDOI
Why do cancers have high aerobic glycolysis
TL;DR: In this article, the authors propose that persistent metabolism of glucose to lactate even in aerobic conditions is an adaptation to intermittent hypoxia in pre-malignant lesions, which leads to microenvironmental acidosis requiring evolution to phenotypes resistant to acid-induced cell toxicity.
Related Papers (5)
Downregulating microRNA-144 mediates a metabolic shift in lung cancer cells by regulating GLUT1 expression.
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
Qin Wu,Qin Wu,Qin Wu,Wail Ba-alawi,Wail Ba-alawi,Geneviève Deblois,Jennifer Cruickshank,Shili Duan,Evelyne Lima-Fernandes,Evelyne Lima-Fernandes,Jillian Haight,Seyed Ali Madani Tonekaboni,Seyed Ali Madani Tonekaboni,Anne-Marie Fortier,Hellen Kuasne,Trevor D. McKee,Hassan Mahmoud,Hassan Mahmoud,Hassan Mahmoud,Michelle Kushida,Sarina Cameron,Sarina Cameron,Nergiz Dogan-Artun,Nergiz Dogan-Artun,Wenjun Chen,Yan Nie,Yan Nie,Yan Nie,Lan Xin Zhang,Ravi N. Vellanki,Stanley Zhou,Stanley Zhou,Panagiotis Prinos,Bradly G. Wouters,Bradly G. Wouters,Peter B. Dirks,Susan J. Done,Morag Park,David W. Cescon,Benjamin Haibe-Kains,Mathieu Lupien,Mathieu Lupien,Cheryl H. Arrowsmith,Cheryl H. Arrowsmith,Cheryl H. Arrowsmith +44 more